medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2022, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2022; 20 (2)

Mesotherapy dutasteride application technique on scalp

Alvarado DA

Language: Spanish
References: 16
Page: 201-204
PDF size: 171.82 Kb.


ABSTRACT

The use of the mesotherapy technique as a therapeutic alternative has been described for several decades, it is based on the infiltration of drugs into the dermis as a route of direct and indirect administration of drugs. Currently, this method has become popular for the application of medications in various pathologies of the scalp, such as androgenetic alopecia (aga). One of the currently used medications applied by mesotherapy is dutasteride, for which we carry out a review narrative of the literature on the mesotherapy technique for the application of this medication as an alternative or in association with oral therapy with antiandrogens.


REFERENCES

  1. Ihrisky SA, Mesotherapy in trichology, Cas Lek Cesk 2017; 156(3):145-6.pmid: 28722459.

  2. Oliveira F, Machado A y Neves PE, Mesotherapy: a bibliographical review,An Bras Dermatol 2011; 86(1):96-101. pmid: 21437529. doi: 10.1590/s0365-05962011000100013.

  3. Sobhy N, Aly H, El Shafee A y El Deeb M, Evaluation of the effectof injection of dutasteride as mesotherapeutic tool in treatment ofandrogenetic alopecia in males, Our Dermatol Online 2013; 4(1):40-45.doi: 10.7241/ourd.20131.08.

  4. Moftah N, Abd-Elaziz G, Ahmed N, Hamed Y, Ghannam B et al., Mesotherapyusing dutasteride-containing preparation in treatment offemale pattern hair loss: photographic, morphometric and ultrastructuralevaluation, J Eur Acad Dermatol Venereol 2013; 27:686-693. doi.org/10.1111/j.1468-3083.2012.04535.x.

  5. Arif T, Dorjay K, Adil M y Sami M, Dutasteride in androgenetic alopecia:an update, Curr Clin Pharmacol 2017; 12(1):31-5. doi: 10.2174/1574884712666170310111125.

  6. Abdallah MA, El-Zawahry KA y Besar H, Mesotherapy using dutasteride-containing solution in male pattern hair loss: a controlled pilotstudy, J Pan Arab Leag Dermatol 2009; 20:137-45.

  7. Saceda-Corralo D, Rodrigues-Barata AR, Vaño-Galván S y Jaén-OlasoloP, Mesotherapy with dutasteride in the treatment of androgeneticalopecia, Int J Trichol 2017; 9:143-5. doi: 10.4103/ijt.ijt_73_16.

  8. Flores SG, El antecedente personal patológico en la anamnesis, RevCostarr Salud Publica 2015; 24(1):49-53.

  9. Bilbao N, Antisépticos y desinfectantes, Elsevier, 2009, pp. 37-39.

  10. Sánchez C et al., Anestesia locorregional de la cabeza en cirugía dermatológica:generalidades, Enferm Dermatol 2017; 11(30): 26-7.

  11. Williams AC y Barry BW, Skin absorption enhances. Critical reviewsin therapeutic drug carrier system, 1992; 9(3,4):305-53. pmid: 1458546.

  12. Arribas JM et al., Uso de anestésicos tópico, fmc 2003; 10(3):189-99.doi: 10.1016/S1134-2072(03)75858-7.

  13. Gallardo J y Pessa D, Bloqueo del cuero cabelludo, Rev Chil Anest 2013;42:294-98.

  14. Blanco RM, Jiménez LD, Vila I y Castro MM, Procedimiento de administraciónde medicación por vía intradérmica, Servizo Galego deSaúde, 2019.

  15. Kim JT, Choi A, Jeong JH, Jo JH, Ryu OK, Kim EJ et al., Safety evaluationand consideration of 4 pin multi-needle for mesotherapy, TechnolHealth Care 2018; 26(S1):291-306. doi: 10.3233/THC-174624.

  16. De Melo R, De Mattos T, Weffort F, Jorge C y Fernandes D, Use of vibratinganesthetic device reduces the pain of mesotherapy injections:a randomized split-scalp study, J Cosmet Dermatol 2021; 20(2):425-8.doi: 10.1111/jocd.13554.




2020     |     www.medigraphic.com